GSK Rights. Subject to Section 10.1.3, GSK shall have the primary right to determine and control a course of action designed to curtail a Third Party Infringement in the Field in the Territory at its own expense. GSK shall keep CureVac closely informed as to any legal courses of action it pursues pursuant to this Section 10.1.2, and the Parties shall consult with each other, and agree on strategic decisions and their implementation in connection with such action.
Appears in 3 contracts
Samples: Covid Cla Third Amendment and Restatement Agreement (CureVac N.V.), Covid Collaboration and License Agreement, Covid Collaboration and License Agreement (CureVac N.V.)
GSK Rights. Subject to Section 10.1.310.4, GSK shall have the primary right to determine and control a course of action designed to curtail a Third Party Infringement in the Field in the Territory at its own expense. GSK shall keep CureVac closely informed as to any legal courses of action it pursues pursuant to this Section 10.1.210.3, and the Parties shall consult with each other, and agree on strategic decisions and their implementation in connection with such action.
Appears in 3 contracts
Samples: Fourth Amendment and Restatement Agreement (CureVac N.V.), 2020 Cla Amendment and Restatement Agreement (CureVac N.V.), Collaboration and License Agreement (CureVac B.V.)
GSK Rights. Subject to Section 10.1.3, GSK shall have the primary right to determine and control a course of action designed to curtail a Third Party Infringement in the Field in the Territory at its own expense. GSK shall keep CureVac closely informed as to any legal courses of action it pursues pursuant to this Section 10.1.2, and the Parties shall consult with each other, and agree on strategic decisions and their implementation in connection with such action.. β
Appears in 1 contract
Samples: Covid Cla Amendment and Restatement Agreement (CureVac N.V.)
